Basis of Presentation and Summary of Significant Accounting Policies - Net Loss Per Share (Details) - shares	12 Months Ended
Dec. 31, 2023	Dec. 31, 2022
Impairment Effects on Earnings Per Share [Line Items]
Number of warrants issued (in shares)	600,018	600,018
December 2021 Private Placement \| Pre-Funded Warrants
Impairment Effects on Earnings Per Share [Line Items]
Number of warrants issued (in shares)		196,978
Convertible Preferred Stock
Impairment Effects on Earnings Per Share [Line Items]
Antidilutive securities excluded from computation of earnings per share (in shares)	25,000

Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Topic 260
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (c)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147482662/260-10-50-1

Name:	us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
Namespace Prefix:	us-gaap_
Data Type:	xbrli:sharesItemType
Balance Type:	na
Period Type:	duration